BioProtect is advancing rectal spacing through controllable, biodegradable balloon technology. Our proprietary balloon spacer is engineered to provide consistent, predictable separation from apex to base, enabling modern, high-precision radiation therapy. The FDA-cleared BioProtect Balloon Spacer has shown reduced rectal dose, a favorable safety profile, and durable preservation of bowel, urinary, and sexual quality of life through 48 months. Its performance supports use across today’s advanced prostate cancer treatment regimens, including hypofractionation and SBRT.
| Website | http://www.bioprotect.com |
| Revenue | $11.8 million |
| Employees | 112 (84 on RocketReach) |
| Founded | 2004 |
| Address | 6 HaGavish, Netanya, Center District, IL |
| Phone | +972 9-773-1929 |
| Technologies |
JavaScript
,
HTML
,
PHP
+17 more
(view full list)
|
| Industry | Medical Devices, Health Care, Medical Device |
| Web Rank | 9 Million |
| Keywords | Oncology Technology, Radiation Protection, Cancer Treatment Technology, Radiation Oncology, Minimally Invasive, Medical Devices, Balloon Technology, Cancer Treatment, Radiation Therapy, Clinical Applications, Radiation Shielding, Medical Technology, Healthcare Technology, Radiation Safety |
| Competitors | BASF, Syngenta, DuPont, CERTIS USA LLC, BioSafe Systems, Biobest Group, Virox Technologies Inc., EcoSMART Technologies, Intermediate Technological Development Group, Eco Terra +28 more (view full list) |
Looking for a particular BioProtect Ltd employee's phone or email?
The BioProtect Ltd annual revenue was $11.8 million in 2026.
Shaul Shohat is the Co-Founder, CTO of BioProtect Ltd.
84 people are employed at BioProtect Ltd.
BioProtect Ltd is based in Netanya, Center District.